Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
locally-employed laboratory personnel, ensuring all laboratory activities related to the LSHTM-COMAHS programme and ancillary and future studies are performed in strict accordance to Good Clinical
-
CoSector CoSector – University of London is a digital services provider that operates as part of the University of London. It evolved from the University of London Computer Centre (ULCC), established in 1968
-
programme. About the CoSTAR National Lab : The CoSTAR National Lab is the largest ever investment in creative industries R&D by UKRI. A £51.1m programme led by Royal Holloway, University of London to develop
-
and self-motivated postdoctoral researcher with a strong background in molecular and cellular biology, as well as computational biology. A track record of effective communication, teamwork and
-
View All Vacancies Directorate of Learning and Wellbeing Location: Camden (Kings Cross, London) / Hawkshead (nr Potters Bar, Herts) Salary: £39,969 to £50,760 Per Annum Including London Weighting Permanent / Full Time Closing Date: 23.59 hours BST on Sunday 24 August 2025 Interview Date: To be...
-
health researcher is sought with expertise in quantitative surveys, mathematical modeling in nutrition (especially in Sudan), and crisis clinical nutrition program management. The ideal candidate should
-
assist with the delivery of teaching across the programme and will have the opportunity to co-lead a module. You will also assist with assessment and student support duties. The post holder will be
-
Television School, Pinewood, and the University of Surrey. This vital role works across the University’s Research and Innovation team and the StoryFutures Business unit to drive an ambitious R&D programme to
-
. The main responsibilities of the post are to support the Employer Engagement and Communications Manager in developing the annual Employer Engagement programme, forging strategically important relationships
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing